News from boston scientific corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

11 Mar, 2019, 11:00 GMT Boston Scientific Announces Scheduled Data at EHRA 2019 Congress

Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at EHRA 2019, the annual congress of the European Heart...


31 Jan, 2019, 12:00 GMT Boston Scientific Launches Spectra WaveWriter™ Spinal Cord Stimulator System in Europe

Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System in Europe. The...


26 Sep, 2018, 13:00 BST Boston Scientific launches GUIDE™ XT System for Visualization of Deep Brain Stimulation in Europe

Boston Scientific Corporation (NYSE: BSX) today announced the launch of the GUIDE™ XT System for visualization of Deep Brain Stimulation (DBS) in...


29 May, 2018, 08:30 BST Boston Scientific Launches the HeartLogic™* Heart Failure Diagnostic in Europe

Boston Scientific Europe today announced the launch of the HeartLogic™ Heart Failure Diagnostic in Europe. With this launch, the first and only...


18 Sep, 2017, 11:30 BST Real-World Data Confirms Long-Term Effectiveness Of Bronchial Thermoplasty

Boston Scientific (NYSE: BSX) today announced results from a three year follow-up cohort in its Post-FDA Approval Clinical Trial Evaluating Bronchial ...


14 Jun, 2016, 13:30 BST National Institute for Health and Care Excellence Provides Positive Guidance for Use of Boston Scientific GreenLight XPS™ Laser Therapy System in the Treatment of BPH

Boston Scientific Corporation (NYSE: BSX) today announced that its GreenLight XPS™ Laser Therapy System, used for the treatment of prostatic...


28 Jan, 2016, 12:00 GMT Boston Scientific and Accenture Develop Data-Driven Digital Health Solution to Help Improve Patient Outcomes and Reduce Cost of Treating Chronic Cardiovascular Conditions

Boston Scientific Corporation (NYSE: BSX) and Accenture (NYSE: ACN) have developed a cloud-based, data-driven digital health solution for hospitals...


10 Sep, 2015, 14:00 BST Boston Scientific Announces CE Mark for the Vercise™ Primary Cell Deep Brain Stimulation System

Boston Scientific (NYSE: BSX) has received CE Mark for the Vercise™ Primary Cell (PC) Deep Brain Stimulation (DBS) System. The Vercise PC System is...


10 Jun, 2015, 14:00 BST New Data Demonstrate Greater Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord Stimulator System

Boston Scientific Corporation (NYSE: BSX) presented new data demonstrating that the Precision Spectra™ Spinal Cord Stimulator (SCS) System provided 1....


04 Jun, 2015, 14:00 BST Boston Scientific Launches The Precision Novi™ Spinal Cord Stimulator System in Europe

Boston Scientific announces the European launch of the Precision Novi™ Spinal Cord Stimulator (SCS) System at the International Neuromodulation...


16 Oct, 2014, 21:42 BST Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the ACCOLADE™ pacemaker family. When implanted with the company's...


30 Aug, 2014, 17:50 BST Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first...


11 Jun, 2014, 23:00 BST Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise™ DBS System

Patients with Parkinson's disease (PD) treated with the Boston Scientific Corporation (NYSE: BSX) Vercise™ Deep Brain Stimulation (DBS) System...


10 Jun, 2014, 23:28 BST Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise™ DBS System For Patients With Parkinson's Disease

A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise™ Deep Brain...


21 May, 2014, 14:19 BST Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corporation (NYSE: BSX) Lotus™ Valve ...


21 May, 2014, 13:00 BST Boston Scientific Reports Strong Performance Data For SYNERGY™ Stent System

Boston Scientific Corporation (NYSE: BSX) reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and...


15 Apr, 2014, 21:50 BST Boston Scientific Announces FDA Approval Of Innovative New Defibrillators And Heart Failure Devices

Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to ...


25 Mar, 2014, 07:00 GMT Boston Scientific anuncia el marcado CE y primeros implantes para los electrodos de estimulación cardiacarm INGEVITY(TM)

 content="MSHTML 8.00.6001.19394">El primer implante se ha realizado en Francia, en las Nouvelles Cliniques Nantaises de Nantes. Boston Scientific...


17 Mar, 2014, 07:00 GMT Boston Scientific Announces CE Mark Approval and First Implants of Ingevity[TM] MRI Pacing Leads

- First implant took place in France, at the Nouvelles Cliniques Nantaises in Nantes Boston Scientific Corporation (NYSE: BSX) announces CE Mark...


12 Mar, 2014, 22:53 GMT Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System

Continuing to advance leading stent technology, Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the REBEL™ Platinum...


14 Feb, 2014, 18:07 GMT Boston Scientific WallFlex™ Esophageal Stent Gains CE Mark For The Treatment Of Refractory Benign Esophageal Strictures

Boston Scientific Corporation (NYSE: BSX) has received CE Mark in Europe for its WallFlex™ Esophageal Fully Covered Stent to treat refractory benign...


17 Dec, 2013, 13:18 GMT Boston Scientific Announces CE Mark Approval And First Implants Of Its Next-Generation X4 Quadripolar CRT-D Systems

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval of its X4 line of quadripolar CRT-D systems, including the AUTOGEN™ X4,...


19 Nov, 2013, 09:00 GMT Boston Scientific Vercise™ Deep Brain Stimulation System Receives CE Mark Approval for Treatment of Dystonia

First System To Selectively Stimulate Targeted Areas Of The Brain To Manage Symptoms of Debilitating Disease The Boston Scientific Corporation (NYSE: ...


15 Nov, 2013, 16:06 GMT Boston Scientific Announces First Commercial Implants Of The Lotus™ Valve System in Europe

Marking a major step forward in the evolution of Transcatheter Aortic Valve Implantation (TAVI) technology, the first two commercial implants of the...


31 Oct, 2013, 21:54 GMT Boston Scientific Lotus™ Valve System Meets Primary Performance Endpoint In REPRISE II Trial

The Boston Scientific Corporation (NYSE: BSX) Lotus™ Valve System met a key performance measure in the treatment of symptomatic patients with severe...